Needham initiates coverage on CAMP4 Therapeutics Corp (NASDAQ: CAMP) with a Buy rating and a price target of $8.00.

For an analyst ratings summary and ratings history on CAMP4 Therapeutics Corp click here. For more ratings news on CAMP4 Therapeutics Corp click here.

Shares of CAMP4 Therapeutics Corp closed at $3.43 yesterday.